News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Levitsky Hyam
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2023 |
4
| Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 25,200 options to buy
@ $17.66, valued at
$445k
|
|
| 04/05/2022 |
4
| Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $18.26, valued at
$301.3k
|
|
| 01/27/2022 |
4
| Levitsky Hyam (President of R&D) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 105,000 options to buy
@ $13.15, valued at
$1.4M
|
|
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2020 |
4
| Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $9.78, valued at
$161.4k
|
|
| 04/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2018 |
4
| Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 27,000 options to buy
@ $15, valued at
$405k
|
|
| 07/19/2018 |
3
| Levitsky Hyam (Director) has filed a Form 3 on Replimune Group, Inc. |
| 02/09/2017 |
4
| Levitsky Hyam (EVP, Research & CSO) has filed a Form 4 on Juno Therapeutics, Inc. |
| 06/21/2016 |
4
| Levitsky Hyam (EVP, Research & CSO) has filed a Form 4 on Juno Therapeutics, Inc. |
| 05/27/2016 |
4
| Levitsky Hyam (EVP, Research & CSO) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 16,454 shares
@ $42.04, valued at
$691.7k
|
|
| 02/04/2016 |
4
| Levitsky Hyam (See Remarks) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $24.5, valued at
$2.5M
|
|
| 06/01/2015 |
4
| Levitsky Hyam (See Remarks) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 145,000 shares
@ $0
Granted 175,000 options to buy
@ $50.6, valued at
$8.9M
|
|
| 09/16/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2011 |
4
| Levitsky Hyam (Director) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 5,989 options to buy
@ $0.897, valued at
$5.4k
|
|
| 06/20/2011 |
4
| Levitsky Hyam (Director) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 15,000 options to buy
@ $0.81, valued at
$12.2k
|
|
| 04/05/2011 |
4
| Levitsky Hyam (Director) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 5,644 options to buy
@ $0.952, valued at
$5.4k
|
|
| 06/15/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2010 |
4
| Levitsky Hyam (Director) has filed a Form 4 on ANTIGENICS INC /DE/|
Txns:
| Granted 15,000 options to buy
@ $1.24, valued at
$18.6k
|
|
| 06/15/2009 |
4
| Levitsky Hyam (Director) has filed a Form 4 on ANTIGENICS INC /DE/ |
| 03/03/2009 |
4
| Levitsky Hyam (Director) has filed a Form 4 on ANTIGENICS INC /DE/ |
| 01/05/2009 |
4
| Levitsky Hyam (Director) has filed a Form 4 on ANTIGENICS INC /DE/ |
|
|